Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has issued an announcement.
Guangzhou Baiyunshan Pharmaceutical Holdings Company has announced the distribution of its 2025 interim dividend, set at RMB0.40 per share, payable in cash. The dividend will be distributed to shareholders whose names appear on the register by September 8, 2025, with payments expected on September 26, 2025. The announcement outlines the tax implications for different categories of shareholders, including non-resident enterprise shareholders who will face a 10% withholding tax, while resident enterprise shareholders are exempt. This move reflects the company’s commitment to returning value to its shareholders and may impact its financial standing and investor relations.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$21.70 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a joint stock company with limited liability established in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.
Average Trading Volume: 1,599,749
Technical Sentiment Signal: Buy
Current Market Cap: HK$45B
For a thorough assessment of 0874 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money